Clinical Trial Update: Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oxaliplatin and docetaxel with radiation therapy in unresectable stage II/III or recurrent non-small cell lung cancer; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED